A Pilot Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Study of Ketogenic Diet and Metformin in Glioblastoma: Feasibility and Metabolic Imaging
Sponsor: Internal Funding
Enrolling: Male and Female Patients
IRB Number: AAAS0279
Contact: Research Nurse Navigator: 212-342-5162 / cancerclinicaltrials@cumc.columbia.edu
Additional Study Information: The purpose of the study is to evaluate the tolerability of a ketogenic diet in conjunction with metformin in people with malignant glioma. The study doctors will try to determine if maintaining the ketogenic diet with metformin will have any effect on your tumor.
This study is closed
Investigator
Andrew Lassman, MD
Do You Qualify?
Are you 18 years of age or older? Yes No
Have you been diagnosed with high-grade glioma? Yes No
Are you receiving any other investigational drugs? Yes No
Submit
Cancel
You may be eligible for this study

Place Holder



Cancel
For more information, please contact:
Research Nurse Navigator
cancerclinicaltrials@cumc.columbia.edu
212-342-5162
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE